---
title: "Vazyme: Plans to establish a joint venture with Yimiao Shenzhou, holding 50% of the shares"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/254955499.md"
description: "Vazyme has signed an agreement with Yimiao Shenzhou to jointly establish a biopharmaceutical joint venture with a registered capital of 40 million yuan, with both parties holding 50% of the shares. The joint venture will focus on the field of cell therapy, dedicated to the screening, prevention, and treatment of Alzheimer's disease. This investment does not require review by the board of directors or shareholders' meeting and is expected to have no significant impact on the performance for the year 2025"
datetime: "2025-08-28T08:45:07.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/254955499.md)
  - [en](https://longbridge.com/en/news/254955499.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/254955499.md)
---

# Vazyme: Plans to establish a joint venture with Yimiao Shenzhou, holding 50% of the shares

Vazyme announced that the company recently signed a "Cell Therapy Cooperation Project Development Agreement" with Yimiao Shenzhou, intending to jointly establish a biopharmaceutical company with a registered capital of RMB 40 million, with both parties holding 50% of the shares. The joint venture will carry out investment cooperation projects in the field of cell therapy, aiming to empower the full-cycle prevention and treatment of Alzheimer's disease through technological innovation. This investment does not require submission for approval by the company's board of directors or shareholders' meeting, does not constitute a related party transaction or a major asset reorganization, and is expected to have no significant impact on the company's performance in 2025

### Related Stocks

- [688105.CN](https://longbridge.com/en/quote/688105.CN.md)

## Related News & Research

- [Flow Pharma U.S. Patent Application Allowed for Issuance Covering Broad-Spectrum Ebola Therapy](https://longbridge.com/en/news/287076761.md)
- [Oil little changed as traders await breakthrough in US.-Iran negotiations](https://longbridge.com/en/news/286925961.md)
- [05:20 ETThrough the America's Most Artistic Kid Competition, Colossal Raises $1.6 Million While Celebrating the Next Gen of Creative Visionaries](https://longbridge.com/en/news/287037755.md)
- [08:03 ETNCCN reafirma su compromiso con los recursos para el manejo del malestar relacionado con el cáncer](https://longbridge.com/en/news/287060831.md)
- [09:20 ETHaier Signs Four-Year Sponsorship with Al Ahly FC, Becoming the Club's Second Main Sponsor](https://longbridge.com/en/news/287073987.md)